Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,105 across all filing types
Latest filing 2022-06-09 Director's Dealing
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing
2022-06-09 English
Director's Dealing 2022
Director's Dealing
2022-06-09 English
Director's Dealing 2022
Director's Dealing
2022-05-31 English
SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the calendar year ended December 31, 2021. It references the Conflict Minerals Report as an exhibit and provides a link to the report but does not contain full financial statements or detailed financial analysis. The document length is short (2206 characters), and it primarily serves as a disclosure filing rather than a full report. According to the filing definitions and rules, Form SD filings are specialized disclosures and do not fit into categories like Annual Report (10-K) or Interim Report (IR). They are regulatory filings related to compliance disclosures. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-05-26 English
Regulatory Filings 2022
Regulatory Filings
2022-05-09 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Johnson & Johnson. Form S-8 is used to register securities to be offered under employee benefit plans, such as stock options or incentive plans. The text includes details about the registration of shares under long-term incentive plans, references to incorporation by reference of other filings (10-K, 10-Q, 8-K), and legal and indemnification information. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or proxy material, but a formal SEC filing for registration purposes.
2022-04-29 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.